IGC Pharma (IGC) Cash & Equivalents (2010 - 2026)
IGC Pharma (IGC) reported Cash & Equivalents of $235000.0 for Q1 2026, down 41.98% year-over-year from $405000.0 in Q1 2025, and down 74.95% quarter-over-quarter from $938000.0 in Q4 2025.
IGC Pharma (IGC) Cash & Equivalents (2010 - 2026) Analysis & Trends
IGC Pharma (IGC) has 17 years of Cash & Equivalents data on file, last reported at $235000.0 in Q1 2026.
- Cash & Equivalents for Q1 2026 came in at $235000.0, down 41.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $235000.0 (down 41.98% YoY), and the FY2026 annual result was $235000.0, down 41.98% from the prior year.
- Cash & Equivalents eased to $235000.0 in Q1 2026 per IGC's latest filing, from $938000.0 in the prior quarter.
- Over five years, Cash & Equivalents peaked at $10.5 million in Q1 2022 and troughed at $235000.0 in Q1 2026.
- A 5-year average of $2.8 million and a median of $1.5 million in 2024 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2023 and 2025: Cash & Equivalents plunged 75.79% in 2023, then surged 99.57% in 2025.
- A 5-year view of Cash & Equivalents shows it stood at $5.0 million in 2022, then slumped by 72.62% to $1.4 million in 2023, then tumbled by 65.89% to $470000.0 in 2024, then surged by 99.57% to $938000.0 in 2025, then plunged by 74.95% to $235000.0 in 2026.
- Business Quant data shows IGC's Cash & Equivalents at $235000.0 in Q1 2026, $938000.0 in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 1.91 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 2.77 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 18.44 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 7.15 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 5.49 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 558.94 Mn |
| 10 | IGC Pharma | 27.49 Mn | 27.22 Mn | - | 235,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 235,000.00 |
| Dec 31, 2025 | 938,000.00 |
| Sep 30, 2025 | 1.13 Mn |
| Jun 30, 2025 | 454,000.00 |
| Mar 31, 2025 | 405,000.00 |
| Dec 31, 2024 | 470,000.00 |
| Sep 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 1.82 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Sep 30, 2023 | 3.03 Mn |
| Jun 30, 2023 | 1.95 Mn |
| Mar 31, 2023 | 3.35 Mn |
| Dec 31, 2022 | 5.03 Mn |
| Sep 30, 2022 | 6.62 Mn |
| Jun 30, 2022 | 8.05 Mn |
| Mar 31, 2022 | 10.46 Mn |
| Dec 31, 2021 | 11.94 Mn |
| Sep 30, 2021 | 14.40 Mn |
| Jun 30, 2021 | 13.32 Mn |